Gold, Silver Focus ...
Health Care: Drugs
Momenta Pharmaceuticals Inc. (MNTA: NASDAQ)
$12.85 -0.02 | -0.16%
05/21/13 - 11:44 AM ET
114.45K / 313.40K
Vol / Avg. Vol:12.83 / 12.87
Open / Prev. Close:12.77 - 12.97
Today's Range:10.05 - 17.09
52 Wk Range:10.52%
Performance YTD:TheStreet Rating:
Portfolios with MNTA
- Portfolio NameUser Type
- UserSm. Magic July 5 13
- ProDiscovery Capital Management
- ContributorTop-Rated Biotechnology Stocks
- Contributor8 Pharma Stocks to Watch
- Contributor10 Stocks With Highest Prof...
- ContributorRelative Strength Stocks 09...
- UserMF
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Poised to Sta...
Latest MNTA Headlines from TheStreet
- Momenta Pharmaceuticals Announces Date Of First Quarter 2013 Financial Results Conference Call And Webcast 04.09.13 | 04:04 pm
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 02.25.13 | 04:02 pm
- Momenta Pharmaceuticals Reports Fourth Quarter And Year End 2012 Financial Results 02.15.13 | 08:02 am
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 02.07.13 | 09:02 am
- Momenta Pharmaceuticals Announces Date Of Fourth Quarter And Year End 2012 Financial Results Conference Call And Webcast 01.24.13 | 08:01 am
- TheStreet Ratings Top 10 Rating Changes 12.03.12 | 02:12 pm
- Momenta Pharmaceuticals Inc. Stock Downgraded (MNTA) 12.03.12 | 04:12 am
- Momenta Pharmaceuticals Announces Date Of Third Quarter 2012 Financial Results Conference Call 10.18.12 | 04:10 pm
- Momenta Pharmaceuticals' CEO To Present At Morgan Stanley Healthcare Conference (Transcript) 09.12.12 | 11:09 am
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 08.30.12 | 05:08 pm
Press Releases for MNTA
- Baxter And Momenta Announce Collaboration To Develop And Commercialize Follow-On Biologics - Business Wire 12.22.11 | 04:12 pm
Partner Headlines for MNTA
- Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? - Seeking Alpha 07.18.12 | 09:07 am
- Company News for June 26, 2012 - Corporate Summary - Zacks 06.26.12 | 10:06 am
- Cemex RISES 7% to Lead These 2 NYSE Top Percentage Winners - Wall St. Cheat Sheet 06.26.12 | 09:06 am
- Teva Jumps, But Still Must Repair Its Chart Further - Investor's Business Daily 06.25.12 | 05:06 pm
- Stocks Open In The Red: Teva Pharmaceuticals Surges - Investor's Business Daily 06.25.12 | 10:06 am
- Morning Market Losers - Benzinga 06.25.12 | 09:06 am
- Healthcare Biz Recap: FDA PROBES Pfizer's New Drug, Ventrus Biosciences ABANDONS Treatment - Wall St. Cheat Sheet 06.25.12 | 07:06 am
- Zynga GROWS in Social Gaming Market and 4 Fresh Analyst Insights - Wall St. Cheat Sheet 06.25.12 | 05:06 am
- Analyst Insights: Molycorp, AeroVironment, Teradyne, Pfizer, Momenta Pharma May 29th - Wall St. Cheat Sheet 05.29.12 | 10:05 am
- Notable Options Activity in Momenta Pharmaceuticals Inc - Benzinga 04.19.12 | 12:04 pm
